Clinico-pathological and electron microscopical studies on a coronary dilating agent: 4-4'-diethylaminoethoxyhexestrol-induced liver injuries.
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury; D004048:Diethylamines / Q000009:adverse effects / Q000627:therapeutic use; D004983:Ethanolamines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005347:Fibroblasts; D006529:Hepatomegaly / Q000139:chemically induced; D006589:Hexestrol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007728:Kupffer Cells; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008103:Liver Cirrhosis / Q000139:chemically induced; D008214:Lymphocytes; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D013997:Time Factors; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use
D004048:Diethylamines; D004983:Ethanolamines; D014665:Vasodilator Agents; D006589:Hexestrol